New York, NY, United States of America

Catherine S Spina

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Columbia University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine S Spina. Retrieved from https://idiyas.com/inventor/catherine-s-spina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine S. Spina and a Patent for Combined Cancer Therapies.

Introduction

Catherine S. Spina is an inventor associated with Columbia University in New York, NY, United States. Her patent work addresses a cancer-treatment approach that combines therapies intended to support the body’s immune response and target tumors.

Latest Patents

Spina is named on one patent, titled “Cancer Treatment Method Combining Immunotherapy and Radiotherapy.” The disclosed method involves administering one or more adenosine signaling modulators alongside radiation therapy to a person in need of cancer treatment. In some embodiments, it also includes an immune-based therapy. The patent describes a therapeutic approach; it does not, by itself, establish clinical effectiveness.

Career Highlights

A key highlight of Spina’s listed patent activity is her contribution to research on combining adenosine signaling modulation with radiation therapy, with the possibility of adding an immune-based treatment. The supplied information identifies Columbia University as her institutional affiliation.

Collaborations

Shruti Bansal is identified as Spina’s coworker. The available information does not specify her role in the patent or the nature of their collaboration.

Conclusion

Catherine S. Spina’s patent reflects research into combining radiation therapy with adenosine signaling modulators and, in some embodiments, immune-based therapy as a potential approach to cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…